Novavax, Inc.: Novavax Nuvaxovid COVID-19 Vaccine? Authorized in the United Kingdom for Use as a Booster in Adults
GAITHERSBURG, Md., Nov. 9, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious